FdaApplication
ANDA 216091
Identifiers
- fda_app_no: ANDA216091
Properties
| Property | Value |
|---|---|
| applicant_name | MSN LABORATORIES PRIVATE LTD |
| application_type | ANDA |
| approval_date | 2022-09-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ZIPRASIDONE MESYLATE | ZIPRASIDONE MESYLATE | EQ 20MG BASE/VIAL | POWDER;INTRAMUSCULAR |
1 product